7-Oxabicyclo[2.2.1]heptane-2-carboxylic acid, 3-[(4-methyl-1-piperazinyl)carbonyl]-, (1R,4S)-rel- (BioDeep_00000837939)

   


代谢物信息卡片


7-Oxabicyclo[2.2.1]heptane-2-carboxylic acid, 3-[(4-methyl-1-piperazinyl)carbonyl]-, (1R,4S)-rel-

化学式: C13H20N2O4 (268.14230000000003)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CN1CCN(CC1)C(=O)C2C3CCC(C2C(=O)O)O3
InChI: InChI=1S/C13H20N2O4/c1-14-4-6-15(7-5-14)12(16)10-8-2-3-9(19-8)11(10)13(17)18/h8-11H,2-7H2,1H3,(H,17,18)/t8-,9+,10?,11?/m0/s1

描述信息

D000970 - Antineoplastic Agents
D004791 - Enzyme Inhibitors
C471 - Enzyme Inhibitor

同义名列表

1 个代谢物同义名

7-Oxabicyclo[2.2.1]heptane-2-carboxylic acid, 3-[(4-methyl-1-piperazinyl)carbonyl]-, (1R,4S)-rel-



数据库引用编号

4 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Tamara Mirzapoiazova, Gang Xiao, Bolot Mambetsariev, Mohd W Nasser, Emily Miaou, Sharad S Singhal, Saumya Srivastava, Isa Mambetsariev, Michael S Nelson, Arin Nam, Amita Behal, Leonidas Arvanitis, Pranita Atri, Markus Muschen, François L H Tissot, James Miser, John S Kovach, Martin Sattler, Surinder K Batra, Prakash Kulkarni, Ravi Salgia. Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer. Molecular cancer therapeutics. 2021 10; 20(10):1820-1835. doi: 10.1158/1535-7163.mct-21-0013. [PMID: 34253596]
  • Liubiqi Zhao, Zongyu Liu, Xinyue Deng, Jiabin Wang, Liankun Sun, Limei Fan, Yong Zhang. Polyphyllin VII induces mitochondrial apoptosis by regulating the PP2A/AKT/DRP1 signaling axis in human ovarian cancer. Oncology reports. 2021 02; 45(2):513-522. doi: 10.3892/or.2020.7879. [PMID: 33416159]
  • Xue-Yang Chen, Chang-Zhou Cai, Meng-Li Yu, Ze-Min Feng, Yu-Wei Zhang, Pei-Hao Liu, Hang Zeng, Chao-Hui Yu. LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway. World journal of gastroenterology. 2019 Dec; 25(45):6607-6618. doi: 10.3748/wjg.v25.i45.6607. [PMID: 31832001]
  • Vincent Chung, Aaron S Mansfield, Fadi Braiteh, Donald Richards, Henry Durivage, Richard S Ungerleider, Francis Johnson, John S Kovach. Safety, Tolerability, and Preliminary Activity of LB-100, an Inhibitor of Protein Phosphatase 2A, in Patients with Relapsed Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I Trial. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017 07; 23(13):3277-3284. doi: 10.1158/1078-0432.ccr-16-2299. [PMID: 28039265]